Cadrenal Therapeutics Statistics
NASDAQ: CVKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.70+0.01 (+0.59%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cadrenal Therapeutics by the numbers
Cadrenal Therapeutics has a market capitalization of $7.0 million based on 4.12M shares outstanding. With trailing EPS of $-3.67, Cadrenal Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.6% above its 50-day average and 51.6% below its 200-day average.
Average daily trading volume is 496.14K shares, or about $843,447 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CVKD valuation vs. peer median
| Metric | CVKD | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.01M | $7.00M | +0% |
| Avg. volume | 496.14K | 1.28M | -61% |
Peer median across 8 companies: TCRT, ENSC, CURX, MTVA, IMRN, BFRG, RKTO, VTGN.
Valuation
- Market cap
- $7.01M
- EPS (TTM)
- $-3.67
- Shares outstanding
- 4.12M
Price and trading
- Previous close
- 1.69
- Open
- 1.69
- Day range
- 1.52 – 1.85
- 52-week range
- 0.816 – 12.50
- Beta
- —
- Volume
- 206.57K
- Average volume
- 496.14K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 23, 2026
Additional statistics
- Market Cap
- 7.01M
- Forward Pe
- -0.50
- Eps
- -3.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.50
- Week52 Low
- 0.82
- Avg Volume
- 496.14K
- Shares Outstanding
- 4.12M
- Ma50
- 1.14
- Ma200
- 3.51
- Earnings Date
- Nov 23, 2026
- Pct From52w High
- -86.40%
- Pct From52w Low
- 108.33%